Literature DB >> 22012890

Unfurling of the band 4.1, ezrin, radixin, moesin (FERM) domain of the merlin tumor suppressor.

S D Yogesha1, Andrew J Sharff, Marco Giovannini, Gerard Bricogne, Tina Izard.   

Abstract

The merlin-1 tumor suppressor is encoded by the Neurofibromatosis-2 (Nf2) gene and loss-of-function Nf2 mutations lead to nervous system tumors in man and to several tumor types in mice. Merlin is an ERM (ezrin, radixin, moesin) family cytoskeletal protein that interacts with other ERM proteins and with components of cell-cell adherens junctions (AJs). Merlin stabilizes the links of AJs to the actin cytoskeleton. Thus, its loss destabilizes AJs, promoting cell migration and invasion, which in Nf2(+/-) mice leads to highly metastatic tumors. Paradoxically, the "closed" conformation of merlin-1, where its N-terminal four-point-one, ezrin, radixin, moesin (FERM) domain binds to its C-terminal tail domain, directs its tumor suppressor functions. Here we report the crystal structure of the human merlin-1 head domain when crystallized in the presence of its tail domain. Remarkably, unlike other ERM head-tail interactions, this structure suggests that binding of the tail provokes dimerization and dynamic movement and unfurling of the F2 motif of the FERM domain. We conclude the "closed" tumor suppressor conformer of merlin-1 is in fact an "open" dimer whose functions are disabled by Nf2 mutations that disrupt this architecture.
Copyright © 2011 The Protein Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22012890      PMCID: PMC3302654          DOI: 10.1002/pro.751

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  48 in total

1.  Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP.

Authors:  R Nguyen; D Reczek; A Bretscher
Journal:  J Biol Chem       Date:  2000-12-05       Impact factor: 5.157

2.  Defects in neurofibromatosis 2 protein function can arise at multiple levels.

Authors:  D H Gutmann; R T Geist; H m Xu; J S Kim; S Saporito-Irwin
Journal:  Hum Mol Genet       Date:  1998-03       Impact factor: 6.150

3.  Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.

Authors:  M Giovannini; E Robanus-Maandag; M van der Valk; M Niwa-Kawakita; V Abramowski; L Goutebroze; J M Woodruff; A Berns; G Thomas
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

4.  The structure of the FERM domain of merlin, the neurofibromatosis type 2 gene product.

Authors:  Beom Sik Kang; David R Cooper; Yancho Devedjiev; Urszula Derewenda; Zygmunt S Derewenda
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-02-21

5.  The tumor suppressors Merlin and Expanded function cooperatively to modulate receptor endocytosis and signaling.

Authors:  Sushmita Maitra; Rima M Kulikauskas; Heather Gavilan; Richard G Fehon
Journal:  Curr Biol       Date:  2006-04-04       Impact factor: 10.834

6.  Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.

Authors:  M Laulajainen; T Muranen; O Carpén; M Grönholm
Journal:  Oncogene       Date:  2007-12-10       Impact factor: 9.867

Review 7.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

8.  Normal membrane localization and actin association of the NF2 tumor suppressor protein are dependent on folding of its N-terminal domain.

Authors:  E Brault; A Gautreau; M Lamarine; I Callebaut; G Thomas; L Goutebroze
Journal:  J Cell Sci       Date:  2001-05       Impact factor: 5.285

9.  Phosphoinositide binding and phosphorylation act sequentially in the activation mechanism of ezrin.

Authors:  Bruno T Fievet; Alexis Gautreau; Christian Roy; Laurence Del Maestro; Paul Mangeat; Daniel Louvard; Monique Arpin
Journal:  J Cell Biol       Date:  2004-03-01       Impact factor: 10.539

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  11 in total

1.  A deletion causing NF2 exon 9 skipping is associated with familial autosomal dominant intramedullary ependymoma.

Authors:  Ilyess Zemmoura; Patrick Vourc'h; Agathe Paubel; Béatrice Parfait; Joëlle Cohen; Frédéric Bilan; Alain Kitzis; Cécilia Rousselot; Fabrice Parker; Patrick François; Christian R Andres
Journal:  Neuro Oncol       Date:  2013-12-18       Impact factor: 12.300

2.  miR-409-3p suppresses the proliferation, invasion and migration of tongue squamous cell carcinoma via targeting RDX.

Authors:  Hujie Chen; Jing Dai
Journal:  Oncol Lett       Date:  2018-05-10       Impact factor: 2.967

3.  Influence of Membrane Receptor Lateral Diffusion on the Short-Term Depression of Acetylcholine-Induced Current in Helix Neurons.

Authors:  Natalia A Vasilyeva; Galina B Murzina; Igor I Kireev; Arkady S Pivovarov
Journal:  Cell Mol Neurobiol       Date:  2017-02-24       Impact factor: 5.046

Review 4.  Merlin: the wizard requires protein stability to function as a tumor suppressor.

Authors:  K Adam Morrow; Lalita A Shevde
Journal:  Biochim Biophys Acta       Date:  2012-06-30

5.  Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.

Authors:  Jahan Ali Khajeh; Jeong Ho Ju; Moussoubaou Atchiba; Marc Allaire; Christopher Stanley; William T Heller; David J E Callaway; Zimei Bu
Journal:  J Mol Biol       Date:  2014-05-29       Impact factor: 5.469

6.  Hippo pathway phylogenetics predicts monoubiquitylation of Salvador and Merlin/Nf2.

Authors:  Robert G Wisotzkey; Charlotte E Konikoff; Stuart J Newfeld
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

Review 7.  Ezrin: a regulator of actin microfilaments in cell junctions of the rat testis.

Authors:  N Ece Gungor-Ordueri; Ciler Celik-Ozenci; C Yan Cheng
Journal:  Asian J Androl       Date:  2015 Jul-Aug       Impact factor: 3.285

Review 8.  Role of Merlin/NF2 inactivation in tumor biology.

Authors:  A M Petrilli; C Fernández-Valle
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

9.  Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity.

Authors:  Minja Laulajainen; Maria Melikova; Taru Muranen; Olli Carpén; Mikaela Grönholm
Journal:  J Cell Mol Med       Date:  2012-09       Impact factor: 5.310

10.  Stability of the tumor suppressor merlin depends on its ability to bind paxillin LD3 and associate with β1 integrin and actin at the plasma membrane.

Authors:  Maria Elisa Manetti; Sandra Geden; Marga Bott; Nicklaus Sparrow; Stephen Lambert; Cristina Fernandez-Valle
Journal:  Biol Open       Date:  2012-08-02       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.